Executives who treat capital allocation as a CEO-level strategic discipline are best positioned to thrive in a volatile and increasingly capital-constrained environment.

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

The global Hemostats Market, valued at US$2.80 billion in 2024 stood at US$2.90 billion in 2025 and is projected to advance ...

Bristol-Myers Squibb’s trading volume rocketed to 6.93 billion on July 15, securing the 138th spot in market rankings. The company unveiled a strategic partnership with a biotech firm to develop ...

The global infant formula market is poised for significant growth, projected to rise from USD 54.48 million in 2025 to an ...